Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

In a move that blurs the line between science fiction and reality, Colossal Biosciences, the pioneering de-extinction company backed by countless celebs, has secured $200 million in Series C funding.

Learn More Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth. Dallas- and Boston-based Colossal is making strides in the ...

Colossal has also altered the DNA sequence in chicken primordial germ cells (PGCs), injected them into embryos, and successfully hatched chimeric chicks. Their offspring will be surrogates for dodos.

"Gamebred" has colossal plans in the works ... no one's ever done that before. Maybe even at the Colosseum, we're talking to ...

Dr. Beth Shapiro, Ph.D. (Lead Paleogeneticist and Colossal Scientific Advisory Board Member) and Ben Lamm (Colossal Co-Founder and CEO). Image courtesy of Colossal Biosciences.(Colossal ...